In particular, the MYB-p300 inhibitor celastrol directly blocked the MYB-KIX (kinase-inducible domain interacting domain) interaction of the MYB-p300 complex and showed antiproliferative activity against AML cells along with prolonged survival in an AML mouse model[228]. Here, MYB is linked to acute myeloid leukemia.